2020 AAN Highlights Jak mění malá molekula průběh spinální svalové atrofie?

Title in English 2020 AAN Highlights How does a small molecule change the course of spinal muscle atrophy?


Year of publication 2020
Type Article in Periodical (without peer review)
MU Faculty or unit

Faculty of Medicine

Description Communication of prof. Servaise on the first results achieved with risdiplam in the treatment of infants with spinal muscular atrophy (SMA) type I was originally accepted into the main program of this year's annual American Academy of Neurology Congress. After the congress had to be moved to virtual space due to the COVID-19 pandemic, it was heard during a webcast broadcast on April 28.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info